Neurocognitive Sequelae in Adult Childhood Leukemia Survivors Related to Levels of Phosphorylated Tau

Central nervous system-directed prophylactic chemotherapy increases survival in childhood leukemia, but possible late neurocognitive sequelae remain a concern. We compared intellectual performance (WAIS IV), memory (AVLT), and executive functioning (ANT) between adult leukemia survivors (n = 31) and...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 2017-07, Vol.109 (7)
Main Authors: Elens, Iris, Deprez, Sabine, Danckaerts, Marina, Bijttebier, Patricia, Labarque, Veerle, Uyttebroeck, Anne, Van Gool, Stefaan, D'Hooge, Rudi, Lemiere, Jurgen
Format: Article
Language:English
Subjects:
Adolescent
Adult
Antimetabolites, Antineoplastic - adverse effects
Biomarkers - cerebrospinal fluid
Case-Control Studies
Cognition Disorders - cerebrospinal fluid
Cognition Disorders - chemically induced
Cognition Disorders - pathology
Cross-Sectional Studies
Female
Humans
Lymphoma, Non-Hodgkin - drug therapy
Male
Methotrexate - adverse effects
Neuropsychological Tests
Phosphorylation
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Prognosis
Retrospective Studies
Survival Rate
Survivors
tau Proteins - cerebrospinal fluid
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Central nervous system-directed prophylactic chemotherapy increases survival in childhood leukemia, but possible late neurocognitive sequelae remain a concern. We compared intellectual performance (WAIS IV), memory (AVLT), and executive functioning (ANT) between adult leukemia survivors (n = 31) and control individuals (n = 35). In survivors, cerebrospinal fluid (CSF) levels of phosphorylated Tau (p-Tau) during treatment and total intrathecal methotrexate dose correlated with adult intellectual performance (Pearson's and Spearman's coefficients, respectively). Long-term memory and attentional control, both maturing before survivors' mean age at diagnosis, were unaffected (P > .05 on all four subtests), in contrast to cognitive flexibility and information processing (P < .05 for eight of the subtests), which mature during adolescence. CSF p-Tau and methotrexate dose negatively correlated with intellectual performance (r = -0.414, P = .04 and r = -0.484, P = .007, respectively), but not with each other (r = 0.219, P = .29). These data identify CSF p-Tau as a predictor of late neurocognitive sequelae (in addition to methotrexate dose). Early identification of children at risk could inspire interventions to prevent or remediate chemotherapy-induced cognitive sequelae.
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/djw321